302 related articles for article (PubMed ID: 22042248)
1. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.
Keck-Wherley J; Grover D; Bhattacharyya S; Xu X; Holman D; Lombardini ED; Verma R; Biswas R; Galdzicki Z
Dev Neurosci; 2011; 33(5):451-67. PubMed ID: 22042248
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges.
Bofill-De Ros X; Santos M; Vila-Casadesús M; Villanueva E; Andreu N; Dierssen M; Fillat C
BMC Genomics; 2015 Nov; 16():907. PubMed ID: 26546125
[TBL] [Abstract][Full Text] [Related]
3. Integrated miRNA and mRNA expression profiling in fetal hippocampus with Down syndrome.
Shi WL; Liu ZZ; Wang HD; Wu D; Zhang H; Xiao H; Chu Y; Hou QF; Liao SX
J Biomed Sci; 2016 Jun; 23(1):48. PubMed ID: 27266699
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal expression of microRNAs in the hippocampus of Ts65Dn mice].
Zhang YJ; He XJ; Liu YJ; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):173-8. PubMed ID: 20396359
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains.
Kuhn DE; Nuovo GJ; Terry AV; Martin MM; Malana GE; Sansom SE; Pleister AP; Beck WD; Head E; Feldman DS; Elton TS
J Biol Chem; 2010 Jan; 285(2):1529-43. PubMed ID: 19897480
[TBL] [Abstract][Full Text] [Related]
6. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
Harashima C; Jacobowitz DM; Witta J; Borke RC; Best TK; Siarey RJ; Galdzicki Z
J Comp Neurol; 2006 Feb; 494(5):815-33. PubMed ID: 16374808
[TBL] [Abstract][Full Text] [Related]
8. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
[TBL] [Abstract][Full Text] [Related]
9. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted.
Guedj F; Kane E; Bishop LA; Pennings JLA; Herault Y; Bianchi DW
Biol Psychiatry; 2023 Jul; 94(1):84-97. PubMed ID: 37074246
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
12. Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates.
Gao FJ; Klinedinst D; Fernandez FX; Cheng B; Savonenko A; Devenney B; Li Y; Wu D; Pomper MG; Reeves RH
Acta Neuropathol Commun; 2021 Aug; 9(1):137. PubMed ID: 34399854
[TBL] [Abstract][Full Text] [Related]
13. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model.
Di Franco N; Drutel G; Roullot-Lacarrière V; Julio-Kalajzic F; Lalanne V; Grel A; Leste-Lasserre T; Matias I; Cannich A; Gonzales D; Simon V; Cota D; Marsicano G; Piazza PV; Vallée M; Revest JM
Mol Cell Neurosci; 2022 Mar; 119():103705. PubMed ID: 35158060
[TBL] [Abstract][Full Text] [Related]
15. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
16. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
[TBL] [Abstract][Full Text] [Related]
17. Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Siarey RJ; Kline-Burgess A; Cho M; Balbo A; Best TK; Harashima C; Klann E; Galdzicki Z
J Neurochem; 2006 Aug; 98(4):1266-77. PubMed ID: 16895585
[TBL] [Abstract][Full Text] [Related]
18. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
19. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.
Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ
Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991
[TBL] [Abstract][Full Text] [Related]
20. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
